
The Society for Immunotherapy of Cancer (SITC) is pleased to offer learners the opportunity to complete modules within the Certificate in Cancer Immunotherapy curriculum, supporting the development of foundational knowledge related to cancer immunotherapy. Learners can expect to gain a comprehensive understanding of cancer immunotherapies, including checkpoint inhibitors, cell therapies, and other approaches, as well as the management of side effects, supporting the application of immunotherapy concepts across a range of professional roles.
The All Modules – Non-Certificate Track consists of eight learning modules. Learners may complete any number of modules and will receive a certificate of completion for each module successfully completed (Modules 1–8). This track does not include a final comprehensive assessment and does not confer the SITC Graduate in Cancer Immunotherapy (SITC-G) designation. All modules are approved for CME, CNE, CPE, and MOC credits, except where noted.
Cost of All Modules - Non-Certificate Track
- SITC Member Price: $240
- Non-Member Price: $320
- SITC Member Price for Low to Lower-Middle Income Economies: $0*
*Note: This is not available to those in the industry work setting.
Click here for the List of Low to Lower-Middle Income Economies.
Target Audiences
The Non-Certificate Track is open to learners interested in building knowledge of cancer immunotherapy, including clinicians, researchers, industry professionals, trainees, and others seeking educational exposure to the field. Participants in this track are not eligible to earn the SITC Graduate in Cancer Immunotherapy (SITC-G) designation.
Requirements
There are no eligibility or completion requirements associated with the Non-Certificate Track. Learners may complete modules at their own pace and may earn a certificate of completion for each individual module by successfully completing the associated end-of-module assessment, as applicable.
Certificate Program Task Force
Chair
- Robert L. Ferris, MD, PhD – University of Pittsburgh Medical Center Hillman Cancer Center
Members
- Umar Farooq, MD – University of Iowa
- Silvia Formenti, MD – Weill Cornell Medicine
- Sigrun Hallmeyer, MD – Advocate Medical Group
- Jose Lutzky, MD, FACP – University of Miami Sylvester Cancer Center
- George Weiner, MD – University of Iowa
Learner Notification
This program consists of eight modules. Continuing Education credit information for the modules can be found below, and at the module level. Please note, that each module counts for a maximum of 1.50 AMA PRA Category 1 Credits™ for physicians and 1.50 contact hours for nurses and 1.50 knowledge-based contact hours for pharmacists.
Continuing Education (CE) Language
Physicians / Nurses / Pharmacists

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Society for Immunotherapy of Cancer (SITC). Partners is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement – Upon successful completion of all content in this program, Partners designatse this enduring material for a maximum of 8.5 AMA PRA Category 1 CreditsTM for physicians and 8.5 contact hours for nurses and 8.5 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.
ABIM MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.5 Part 2 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
